Source: Annual Congress 2001 - Treatment of LRTI
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Lorenz, E. S. Dietrich, T. Detering, K. H. Kullmann, T. Welte (Lüdenscheid, Freiburg, Grenzach-Wyhlen, Magdeburg, Germany). Efficacy and cost analysis of ceftriaxone 1 g versus aminopenicillin-betalactamase inhibitors in the treatment of pneumonia on general medical wards. Eur Respir J 2001; 16: Suppl. 31, 921

Member's Comments

No comment yet.

Related content which might interest you: Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives Source: Eur Respir J 2004; 24: Suppl. 48, 185s Year: 2004 Earlier discharge of patients treated with moxifloxacin IV/PO monotherapy (MXF) versus amoxicillin/clavulanate (AMC) ±] clarithromycin (CLA) for community-acquired pneumonia (CAP) results in cost savings to the German and French healthcare Source: Eur Respir J 2002; 20: Suppl. 38, 561s Year: 2002 Effectiveness of once daily meropenem for the treatment of aspiration pneumonia of elderly patients in long-term care facilities Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Practical treatment of community acquired pneumonia (CAP) with outpatient parenteral antibiotic therapy (OPAT) and switch therapy: CTRX and LVFX Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Effectiveness of the empirical administration of antibiotics in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007 Cost-efficacy analysis of cefixime switch therapy in the treatment of community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006 Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia Source: Eur Respir J 2003; 21: 135-143 Year: 2003 Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP) Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis Source: Eur Respir J 2010; 35: 858-864 Year: 2010 Effect on outcome of antibiotic treatment during the 2 weeks before hospital admission for community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Initial intravenous antibiotic regimen in patients hospitalized for community acquired pneumonia (CAP) in France Source: Eur Respir J 2003; 22: Suppl. 45, 151s Year: 2003 Efficacy, safety and tolerability of 3 day azithromycin versus 10-day amoxillin/clavulanic acid in the treatment of children with pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 143s Year: 2003 Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 The effect of educational interventions of administering the first dose of antibiotics within 4 hours on community acquired pneumonia management Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008 Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients Source: Eur Respir J 2005; 26: Suppl. 49, 637s Year: 2005 Short-term efficacy of moxifloxacin (MXF) compared to standard antibiotic treatment (STD) in acute exacerbations of chronic bronchitis (AECB): A multivariate analysis from the MOSAIC study Source: Eur Respir J 2003; 22: Suppl. 45, 351s Year: 2003 Prior outpatient antibiotic use in patients with community acquired pneumonia (CAP) admitted in hospital Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 Potential economic savings of administration of home intravenous antibiotic therapy to patients with acute respiratory infections in Ireland Source: Annual Congress 2011 - The impact of the organisation of care on costs: the role of the physician in home care Year: 2011 Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis Source: Eur Respir J 2008; 31: 1068-1076 Year: 2008 Prescription of antibiotics for the treatment of community acquired pneumonia in a district general hospital in the UK Source: Eur Respir J 2006; 28: Suppl. 50, 350s Year: 2006